Phase I, Single-center, Open Label, Fixed-sequence Cross-over Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 24 Jul 2017
At a glance
- Drugs Cabotegravir (Primary) ; Rifampicin
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors ViiV Healthcare
- 24 Jul 2017 Results assessing effect of Rifampin on the pharmacokinetics of oral Cabotegravir, published in the Antimicrobial Agents and Chemotherapy.
- 18 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.